 ABVC BioPharma Inc NASDAQ: ABVC shares gained during the market trading session on continued momentum from yesterdays dietary supplement distribution deal and after a favorable report from Zacks Small-Cap Research. Yesterday, ABVC Biopharma announced that BioKey would produce dietary supplements derived from the maitake mushroom in tablet and liquid forms. 